Cargando…
Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ
INTRODUCTION: The potential mechanisms governing drug induced osteonecrosis of the jaw (ONJ) is not well understood, and is one of the objectives of this study. Thus, we tested the release of IFN-γ within different immune compartments including bone marrow and gingivae upon treatment with zoledronic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895394/ https://www.ncbi.nlm.nih.gov/pubmed/36742414 http://dx.doi.org/10.3389/fendo.2023.1111627 |
_version_ | 1784881898743398400 |
---|---|
author | Kaur, Kawaljit Sun, Yujie Kanayama, Keiichi Morinaga, Kenzo Hokugo, Akishige Nishimura, Ichiro Jewett, Anahid |
author_facet | Kaur, Kawaljit Sun, Yujie Kanayama, Keiichi Morinaga, Kenzo Hokugo, Akishige Nishimura, Ichiro Jewett, Anahid |
author_sort | Kaur, Kawaljit |
collection | PubMed |
description | INTRODUCTION: The potential mechanisms governing drug induced osteonecrosis of the jaw (ONJ) is not well understood, and is one of the objectives of this study. Thus, we tested the release of IFN-γ within different immune compartments including bone marrow and gingivae upon treatment with zoledronic acid (ZOL) and denosumab which are known to induce ONJ in susceptible individuals. METHODS: We used humanized-BLT mouse model for the in-vivo studies reported in this paper. To determine the effects of zoledronic acid and denosumab on IFN-γ secretion and NK cell-mediated cytotoxicity; peripheral blood, bone marrow, spleen and gingiva were obtained after the injection of ZOL and denosumab in mice. RESULTS: Percentages of B cells are much higher in wild-type mice whereas the proportions of immune subsets in humans and reconstituted hu-BLT peripheral-blood are similar. Therefore, hu-BLT mice are preferable model to study human disease, in particular, immune-pathologies induced by ZOL and denosumab. Both agents resulted in a severe suppression of IFN-γ in the gingiva, whereas they heightened the release of IFN-γ and NK cell-mediated cytotoxicity by the BM-derived immune cells. ZOL increased the IFN-γ secretion by the spleen and peripheral blood immune cells, whereas denosumab decreased the release IFN-γ by these cells significantly. DISCUSSION: ZOL and denosumab may likely suppress IFN-γ secretion in gingiva through different mechanisms. In addition, to the suppression of IFN-γ secretion, denosumab mediated effect could in part be due to the decrease in the bone resorptive function of osteoclasts due to the induction of antibody dependent cellular cytotoxicity and lysis of osteoclasts, whereas ZOL is able to mediate cell death of osteoclasts directly. Suppression of IFN-gamma in gingiva is largely responsible for the inhibition of immune cell function, leading to dysregulated osteoblastic and osteoclastic activities. Restoration of IFN-gamma in the local microenvironment may result in establishment of homeostatic balance in the gingiva and prevention of osteonecrosis of jaw. |
format | Online Article Text |
id | pubmed-9895394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98953942023-02-04 Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ Kaur, Kawaljit Sun, Yujie Kanayama, Keiichi Morinaga, Kenzo Hokugo, Akishige Nishimura, Ichiro Jewett, Anahid Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: The potential mechanisms governing drug induced osteonecrosis of the jaw (ONJ) is not well understood, and is one of the objectives of this study. Thus, we tested the release of IFN-γ within different immune compartments including bone marrow and gingivae upon treatment with zoledronic acid (ZOL) and denosumab which are known to induce ONJ in susceptible individuals. METHODS: We used humanized-BLT mouse model for the in-vivo studies reported in this paper. To determine the effects of zoledronic acid and denosumab on IFN-γ secretion and NK cell-mediated cytotoxicity; peripheral blood, bone marrow, spleen and gingiva were obtained after the injection of ZOL and denosumab in mice. RESULTS: Percentages of B cells are much higher in wild-type mice whereas the proportions of immune subsets in humans and reconstituted hu-BLT peripheral-blood are similar. Therefore, hu-BLT mice are preferable model to study human disease, in particular, immune-pathologies induced by ZOL and denosumab. Both agents resulted in a severe suppression of IFN-γ in the gingiva, whereas they heightened the release of IFN-γ and NK cell-mediated cytotoxicity by the BM-derived immune cells. ZOL increased the IFN-γ secretion by the spleen and peripheral blood immune cells, whereas denosumab decreased the release IFN-γ by these cells significantly. DISCUSSION: ZOL and denosumab may likely suppress IFN-γ secretion in gingiva through different mechanisms. In addition, to the suppression of IFN-γ secretion, denosumab mediated effect could in part be due to the decrease in the bone resorptive function of osteoclasts due to the induction of antibody dependent cellular cytotoxicity and lysis of osteoclasts, whereas ZOL is able to mediate cell death of osteoclasts directly. Suppression of IFN-gamma in gingiva is largely responsible for the inhibition of immune cell function, leading to dysregulated osteoblastic and osteoclastic activities. Restoration of IFN-gamma in the local microenvironment may result in establishment of homeostatic balance in the gingiva and prevention of osteonecrosis of jaw. Frontiers Media S.A. 2023-01-20 /pmc/articles/PMC9895394/ /pubmed/36742414 http://dx.doi.org/10.3389/fendo.2023.1111627 Text en Copyright © 2023 Kaur, Sun, Kanayama, Morinaga, Hokugo, Nishimura and Jewett https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Kaur, Kawaljit Sun, Yujie Kanayama, Keiichi Morinaga, Kenzo Hokugo, Akishige Nishimura, Ichiro Jewett, Anahid Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title | Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title_full | Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title_fullStr | Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title_full_unstemmed | Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title_short | Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ |
title_sort | augmentation of ifn-γ by bone marrow derived immune cells in the presence of severe suppression of ifn-γ in gingivae induced by zoledronic acid and denosumab in hu-blt mice model of onj |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895394/ https://www.ncbi.nlm.nih.gov/pubmed/36742414 http://dx.doi.org/10.3389/fendo.2023.1111627 |
work_keys_str_mv | AT kaurkawaljit augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT sunyujie augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT kanayamakeiichi augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT morinagakenzo augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT hokugoakishige augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT nishimuraichiro augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj AT jewettanahid augmentationofifngbybonemarrowderivedimmunecellsinthepresenceofseveresuppressionofifngingingivaeinducedbyzoledronicacidanddenosumabinhubltmicemodelofonj |